Phase I/II – Other

643 trials 280 recruiting

Filter these 643 trials by condition, country, sponsor and more.

Open in Search →

Study of MK-5684-based Therapies in Advanced Prostate Cancer Recruiting

2023-506288-33-00 Metastatic castration resistant prostate cancer (mCRPC) 2025-03-03
A Clinical Trial for Patients with Advanced Cancers Recruiting

2024-515020-36-00 Advanced Solid tumour 2025-02-24
Pomalidomide as an immune-enhancing agent for the control of HIV (PEACH) Recruiting

2024-512797-10-00 HIV-1-infection 2025-02-13
Pan-tumor Study of I-DXd in Subjects with Recurrent or Metastatic Solid Tumors Recruiting

2023-509632-26-00 Recurrent or Metastatic Solid Tumors (endometrial cance 2025-02-11
A seamless, phase 1b/2 multiple ascending dose/proof of concept study of XTMAB-16 in patients with pulmonary sarcoidosis with or without ext… Recruiting

2022-502877-41-01 Pulmonary sarcoidosis with or without extrapulmonary ma 2025-02-10
PET/CT imaging with FAPI as a biomarker for the distinction between predominant active fibrotic and inflammatory phenotypes in patients with… Recruiting

2023-503686-26-02 Progressive Pulmonary Fibrosis (PPF) 2025-01-24
EEN-RICH study Recruiting

2022-503027-10-00 Crohn's disease 2025-01-21
Intraglandular treatment with adipose derived mesenchymal stem cells in patients with xerostomia due to Sjögrens syndrome (ASSIX) Recruiting

2024-516715-25-00 Sjögrens Syndrone 2025-01-21
Ketamine for depression and alcohol use disorder Recruiting

2023-506052-24-00 Depression 2025-01-20
Double-blind placebo-controlled clinical trial (Phase 1b/2a) to evaluate safety and efficacy of IM-250 administration in patients with recur… Recruiting

2024-516368-27-00 Genital herpes infection 2025-01-16
Deferoxamine in Aneurysmal Subarachnoid Hemorrhage trial Recruiting

2024-514615-10-01 Subarachnoid hemorrhage 2025-01-14
MRI contrast agent in the spinal canal to investigate transportation of the cerebrospinal fluid in the brain. Recruiting

2024-520146-33-00 Cerebrospinal fluid circulation disorder seen in clinic 2025-01-13
ACTME Recruiting

2024-516125-31-02 Metastatic Melanoma 2024-12-18
Phase I/II study to evaluate the efficacy and safety of bacterial collagenase administered in patients with Dupuytren's contracture. Recruiting

2023-507332-20-00 Dupuytren contracture 2024-12-18
A clinical study of sacituzumab tirumotecan (sac-TMT) in people with bladder cancer (MK-2870-027) Recruiting

2024-514983-23-01 Intermediate-risk Non-muscle Invasive Bladder Cancer 2024-12-16
A Phase 1b/2, Open-label Study of Amivantamab Monotherapy and Amivantamab in Addition to Other Therapeutic Agents in Participants with Head … Recruiting

2023-508418-40-00 Head and Neck Squamous Cell Carcinoma 2024-12-16
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Subject… Recruiting

2024-513860-25-00 Ovarian Neoplasms 2024-12-10
Clinical trial of patritumab deruxtecan in people with gastrointestinal cancers Recruiting

2024-512442-41-00 Colorectal Carcinoma, Biliary Tract Carcinoma, Hepatoce 2024-12-03
Tolerogenic dendritic cell therapy in type 1 diabetes; a phase 1b safety and immunological effecitivity study Recruiting

2023-508558-25-01 Type 1 Diabetes 2024-12-02
Phase Ib study combining dinutuximab beta with induction chemotherapy regimens in patients with newly diagnosed high-risk neuroblastoma Recruiting

2023-509673-22-00 Neuroblastoma 2024-12-02
COMparison of B-cell dePletion by rituximAb and anti-CD 19 CAR-T therapy in patients with rhEumatoid arthritis- The COMPARE TRIAL Recruiting

2024-514955-13-00 Rheumatoid Arthritis 2024-11-29
MAGE-C2 TCR T cell therapy Recruiting

2024-516922-70-00 advanced melanoma or HNSCC 2024-11-29
Anti-CD19 CAR T-Cell TherApy in Refractory Systemic Autoimmune DISeases - CATARSIS Recruiting

2024-511293-74-01 Refractory Systemic Autoimmune Diseases 2024-11-26
MEPENDAX: Phase I/II study of axitinib (Inlyta®) and oral metronomic etoposide for pediatric children and AYA with refractory/relapsing medu… Recruiting

2023-509585-38-00 Ependymoma 2024-11-19